Inject TOUJEO subcutaneously once a day into the abdominal area, thigh, or deltoid at the same time each day
Diabetologia 29:4652 Kreymann B, Williams G, Ghatei MA, Bloom SR (1987) Glucagon-like peptide-1 736: a physiological incretin in man
Frequently Asked Questions About Medical Weight Loss Weight loss can be challenging, especially when navigating the process on your own
This dosing schedule and route are consistent with data from the Phase 2 trial published in the New England Journal of Medicine (2023)
To gain the most benefits, follow the dosage instructions on the bottle, taking it as part of your daily routine
Setmelanotide in patients aged 25 years with rare mc4r pathway-associated obesity (Venture): A 1 year, open-label, multicenter, phase 3 trial